UroGen Pharma
URGN
URGN
77 hedge funds and large institutions have $140M invested in UroGen Pharma in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 22 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
16% less funds holding
Funds holding: 92 → 77 (-15)
41% less capital invested
Capital invested by funds: $237M → $140M (-$96.6M)
67% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 21
Holders
77
Holding in Top 10
1
Calls
$5K
Puts
$4K
Top Buyers
| 1 | +$9.75M | |
| 2 | +$1.17M | |
| 3 | +$1.12M | |
| 4 |
CBA
Coastal Bridge Advisors
Westport,
Connecticut
|
+$510K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$441K |
Top Sellers
| 1 | -$2.5M | |
| 2 | -$1.26M | |
| 3 | -$1.24M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$964K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$754K |